The Latest Cardiac and Vascular News
LONDON, April 23, 2018 /PRNewswire/ — Microelectronic Medical Implants Market Analysis Report by Product (Pacemakers & Defibrillators, Neurostimulators, Implantable Drug Pumps, Spinal Fusion Stimulators), by Technology, And Segment Forecasts, 2018 – 2025 Download the full report: https://www.reportbuyer.com/product/5360535 The global microelectronic medical implants market size is anticipated to reach USD 57.12 billion by 2025, according to […]
TEL AVIV, Israel, April 23, 2018 /PRNewswire/ — Vascular Graft Solutions Ltd (VGS) announces on enrollment of the first 20 patients into the VEST US pivotal trial that will evaluate the safety and effectiveness of the VEST, a novel external support device for treatment of saphenous vein graft disease after coronary artery […]
BROOMFIELD, Colo.–(BUSINESS WIRE)–ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc. (NYSE:MDT), a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA’s proposed […]
Angel Medical Systems, Inc. of Tinton Falls announced that they have received FDA pre-market approval on a medical device that detects heart attacks before patients experience symptoms. The AngelMed Guardian System is an implantable heart monitor with internal and external alerting capabilities to urge at-risk patients with pre-existing cardiac conditions […]
SILVER SPRING, Md.–(BUSINESS WIRE)–Aziyo Biologics, Inc., a fully integrated regenerative medicine company, today announced that it has entered into a US co-distribution agreement for its CanGaroo® Bio Envelope with BIOTRONIK, Inc., a global leader in cardio- and endovascular medical technology. CanGaroo Bio Envelopes are a natural extracellular matrix (ECM) scaffold that […]
MILWAUKEE–(BUSINESS WIRE)–APN Health, LLC (www.apnhealth.com) announces its Navik 3D mapping system is commercially released and in clinical use. The first clinical case using the technology was performed on March 22nd at St. Luke’s Medical center in Milwaukee. Navik 3D is intended for catheter-based atrial and ventricular mapping using compatible catheters […]
SEATTLE, April 19, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today it has been recognized as one of the Top 10 Cardio Vascular Device Companies of 2018 by MedTech Outlook Magazine, an industry periodical committed to covering the […]
VANCOUVER, April 17, 2018 /PRNewswire/ – Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced completion of enrollment for the Phase 4 SPECTRUM study evaluating Brinavess® (vernakalant hydrochloride, IV), the Company’s antiarrhythmic drug for the rapid conversion of recent onset atrial fibrillation (AF), in the post-authorization […]
PORTLAND, Oregon and PUNE, India, April 12, 2018 /PRNewswire/ — According to a new report published by Allied Market Research, titled, ” Ventricular Assist Devices Market by Product, Application, and Design: Global Opportunity Analysis and Industry Forecast, 2017-2023,” the global ventricular assist devices market was valued at $809 million in 2016, and is estimated to reach $1,773 million by […]
SANTA CRUZ, Calif.–(BUSINESS WIRE)– Murj, Inc., a healthcare technology company focused on transforming implantable cardiac device management, today announced the availability of OnSite™— the industry’s first cloud-based workflow solution for in-office cardiac device management. OnSite is an extension of Murj’s proven workflow for remote transmission management. With today’s announcement, Murj […]
